Topoisomerase II expression in osseous tissue

Journal of Cellular Biochemistry

Volumn 67, Issue 4, 1997, Pages 451-465

  Feister, Hilary A ^a   Swartz, Darl ^a   Odgren, Paul R ^b   Holden, Joseph ^c   Hock, Janet M ^d,e   Onyia, Jude ^d,e   Bidwell, Joseph P ^a,d  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d INDIANA UNIVERSITY SCHOOL OF DENTISTRY   (United States)

^e ELI LILLY AND COMPANY   (United States)

Author keywords

Bone; Differentiation; Nuclear matrix; Osteoblast; Topoisomerase II

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING);

ALPHA CHAIN; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BETA CHAIN; BONE DEVELOPMENT; CONTROLLED STUDY; ENZYME SUBUNIT; LUMBAR VERTEBRA; MALE; NONHUMAN; OSTEOBLAST; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BONE MARROW CELLS; CELL NUCLEUS; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; DNA TOPOISOMERASES, TYPE II; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GROWTH PLATE; ISOENZYMES; LUMBAR VERTEBRAE; MALE; MICROSCOPY, CONFOCAL; OSTEOBLASTS; OSTEOSARCOMA; RATS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0030694588     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19971215)67:4<451::AID-JCB4>3.0.CO;2-R     Document Type: Article

References (57)

1. Alvarez M, Long H, Onyia J, Hock J, Xu W, Bidwell J (1997): Rat osteoblast and osteosarcoma nuclear matrix proteins bind with sequence specificity to the rat type I collagen promoter. Endocrinology 138(1):482-489.
2. Anderson HJ, Roberge M (1992): DNA topoisomerase II: A review of its involvement in chromosome structure, DNA replication, transcription and mitosis. Cell Biol Inter Rep 16:717-723.
3. Aubin JE, Liu F, Malaval L, Gupta AK (1995): Osteoblast and chondroblast differentiation. Bone 17:77S-83S.
4. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl D (eds) (1987): "Current Protocols in Molecular Biology." New York: John Wiley & Sons, Inc.
5. Bauman ME, Holden JA, Brown KA, Harker WG, Perkins SL (1997): Differential immunohistochemical staining for DNA topoisomerase II-α and -β in human tissues and for DNA topoisomerase II-β in Non-Hodgkin's Lymphomas. Modern Pathol 10:168-175.
6. Beck WT, Danks MK, Wolverton JS, Chen M, Granzen B, Kim R, Suttle DP (1994): Resistance of mammalian tumor cells to inhibitors of DNA topoisomerase II. Adv Pharmacol 29B:145-169.
7. Bidwell J, Feister H, Swartz D, Onyia J, Holden J, Hock J (1996): Parathyroid hormone regulates the expression of osteoblast nuclear matrix proteins. J Cell Biochem 63:374-383.
8. Biersack H, Jensen S, Gromova I, Nielsen IS, Westergaard O, Andersen AH (1996): Active heterodimers are formed from human DNA topoisomerase IIα and IIβ isoforms. Proc Natl Acad Sci USA 93:8288-8293.
9. Brou C, Kuhn A, Staub A, Chaudhary S, Grummt I, Davidson I, Tora L (1993): Sequence-specific transactivators counteract topoisomerase II-mediated inhibition of in vitro transcription by RNA polymerases I and II. Nucleic Acids Res 21:4011-4018.
10. Capranico G, Tinelli S, Austin CA, Fisher ML, Zunino F (1992): Different patterns of gene expression of topoisomerase II isoforms in differentiated tissues during murine development. Biochim Biophys Acta 1132:43-48.
11. Chresta CM, Hall BF, Francis GE (1995): Retinoic acid and phorbol ester induced hyperphosphorylation of topoisomerase II-α is an early event in HL-60 human leukaemia cell differentiation: effect on topoisomerase activity and etoposide sensitivity. Leukemia 9:1373-1381.
12. Constantinou A, Grdina D, Kiguchi K, Huberman E (1992): The effect of topoisomerase inhibitors on the expression of differentiation markers and cell cycle progression in human K-562 leukemia cells. Exp Cell Res 203:100-106.
13. Constantinou AI, Vaughan ATM, Yamasaki H, Kamath N (1996): Commitment to erythroid differentiation in mouse erythroleukemia cells is controlled by alterations in topoisomerase IIα phosphorylation. Cancer Res 56:4192-4199.
14. D'Andrea MR, Farber PA, Foglesong PD (1994): Immunohistochemical detection of DNA topoisomerases IIα and IIβ compared with detection of Ki-67, a marker of cellular proliferation, in human tumors. Appl Immunohistochem 2(3):177-185.
15. Drake FH, Hofmann GA, Bartus HF, Mattern MR, Crooke ST, Mirabelli CK (1989): Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II. Biochemistry 28:8154-8160.
16. Drolet M, Hai-Young W, Liu LF (1994): Role of DNA topoisomerases in transcription. Adv Pharmacol 29A:135-146.
17. Gerbaulet SP, van Wijnen AJ, Aronin N, Tassinari MS, Lian JB, Stein JL, Stein GS (1992): Downregulation of histone H4 gene transcription during postnatal development in transgenic mice and at the onset of differentiation in transgenically derived calvarial osteoblast cultures. J Cell Biochem 49:137-147.
18. Giaccone G (1994): DNA topoisomerases and topoisomerase inhibitors. Path Biol 42:346-352.
19. Goldberg D, Polly P, Eisman JA, Morrison NA (1996): Identification of an osteocalcin gene promoter sequence that binds API. J Cell Biochem 60:447-57.
20. Grigoriadis AE, Schellander K, Wang ZQ, Wagner EF (1993): Osteoblasts are target cells for transformation in c-fos transgenic mice. J Cell Biol 122:685-701.
21. Heck MMS, Earnshaw WC (1986): Topoisomerase II: a specific marker for cell proliferation. J Cell Biol 103:2569-2581.
22. Holden JA, Rolfson DH, Wittwer CT (1992): The distribution of immunoreactive topoisomerase II protein in human tissues and neoplasms. Oncology Res 4(4-5):157-166.
23. Holden JA, Snow GW, Perkins SL, Jolies CJ, Kjeldsberg CR (1994): Immunohistochemical staining for DNA topoisomerase II in frozen and formalin-fixed paraffin-embedded human tissues. Modern Pathology 7:829-834.
24. Holden JA, Perkins SL, Snow GW, Kjeldsberg CR (1995): Immunohistochemical staining for DNA topoisomerase II in Non-Hodgkin's lymphomas. Amer J of Clin Path 104(1):54-59.
25. Juenke JM, Holden JA (1993): The distribution of DNA topoisomerase II isoforms in differentiated adult mouse tissues. Biochim Biophys Acta 1216:191-196.
26. Kroll DJ, Sullivan DM, Gutierrez-Hartman A, Hoeffler JP (1993): Modification of DNA topoisomerase II activity via direct interactions with the cyclic adenosine-3′,5′-monophosphate response element-binding protein and related transcription factors. Mol Endocrin 7:305-318.
27. Lazarides E, Weber K (1974): Actin antibody: the specific visualization of actin filaments in non-muscle cells. Proc Natl Acad Sci USA 71(6):2268-2272.
28. Lynch BJ, Guinee Jr. DG, Holden JA (in press): Human DNA topoisomerase II-alpha: a new marker of cell proliferation in invasive breast cancer. Human Pathol.
29. McCabe LR, Kockx M, Lian J, Stein J, Stein G (1995): Selective expression of fos- and jun-related genes during osteoblast proliferation and differentiation. Experimental Cell Res 218:255-262.
30. Nakaya K, Chou S, Kaneko M, Nakamura Y (1991): Topoisomerase inhibitors have potent differentiation inducing activity for human and mouse myeloid leukemia cells. Jpn J Cancer Res 82:184-191.
31. Negri C, Chiesa R, Cerino A, Bestagno M, Sala C, Zini N, Maraldi NM, and Astaldi-Ricotti GCB (1992): Monoclonal antibodies to human DNA topoisomerase I and the two isoforms of DNA topoisomerase II: 170- and 180-kDa isozymes. Exp Cell Res 200:452-459.
32. Odgren PR, Toukatly G, Bangs PL, Gilmore R, Fey EG (1996): Molecular characterization of mitofilin (HMP), a mitochondria-associated protein with predicted coiled coil and intermembrane space targeting domains. J Cell Science 109:2253-2264.
33. Onyia J, Miller B, Hulman J, Liang J, Galvin R, Frolik C, Chandrasekhar S, Harvey A, Bidwell J, Herring J, Hock J (1997): Proliferating cells in the primary spongiosa express osteoblastic phenotype in vitro. Bone 20:93-100.
34. Onyia JE, Bidwell JB, Herring J, Hulman J, Hock JM (1995): In vivo, human parathyroid hormone fragment (hPTH 1-34) transiently stimulates immediate early response gene expression, but not proliferation, in trabecular bone cells of young rats. Bone 17(5):479-484.
35. Owen TA, Bortell R, Shalhoub V, Heinrichs A, Stein JL, Stein GS, Lian JB (1993): Postproliferative transcription of the rat osteocalcin gene is reflected by vitamin D-responsive developmental modifications in protein-DNA interactions at basal and enhancer promoter elements. Proc Natl Acad Sci USA 90:1503-1507.
36. Petrov P, Drake FH, Loranger A, Huang W, Hancock R (1993): Localization of DNA topoisomerase II in chinese hamster fibroblasts by confocal and electron microscopy. Exp Cell Res 204:73-81.
37. Pockwinse SM, Wilming LG, Conlon DM, Stein GS, Lian JB (1992): Expression of cell growth and bone specific genes at single cell resolution during development of bone tissue like organization in primary osteoblast cultures. J Cell Biochem 49:310-323.
38. Rappa G, Lorico A, Sartorelli AC (1990): Induction of the differentiation of WEHI-3B D+ monomyelocytic leukemia cells by inhibitors of topoisomerase II. Cancer Res 50:6723-6730.
39. Rashid Z, Basson MD (1996): Topoisomerase II inhibition differentially modulates Caco-2 intestinal epithelial cell phenotype. Biochem Biophys Res Comm 219:82-88.
40. Rattner JB, Hendzel MJ, Furbee CS, Muller MT, Bazett-Jones DP (1996): Topoisomerase II alpha is associated with the mammalian centromere in a cell cycle- and species-specific manner and is required for proper centromere kinetochore structure. J Cell Biol 134:1097-1107.
41. Riou JF, Gabillot M, Riou G (1993): Analysis of topoisomerase II-mediated DNA cleavage of the c-myc gene during HL60 differentiation. FEBS Lett 334:369-372.
42. Sahyoun N, Wolf M, Besterman J, Hsieh T, Sander M, LeVine H 3rd, Chang KJ, Cuatrecasas P (1986): Protein kinase C phosphorylates topoisomerase II: topoisomerase activation and its possible role in phorbol ester-induced differentiation of HL-60 cells. Proc Natl Acad Sci USA 83:1603-1607.
43. Stein GS, Lian JB (1993): Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 14:424-442.
44. Stein GS, van Wijnen AJ, Stein J, Lian JB, Montecino M (1995): Contributions of nuclear architecture to transcriptional control. International Rev Cytol 162A:251-278.
45. Swedlow JR, Sedat JW, Agard DA (1993): Multiple chromosomal populations of topoisomerase II detected in vivo by time-lapse, three dimensional wide-field microscopy. Cell 73:97-108.
46. Ura K, Hirose S (1991): Possible role of DNA topoisomerase II on transcription of the homeobox gene Hox-2.1 in F9 embryonal carcinoma cells. Nucleic Acids Res 19:6087-6092.
47. van den Ent FM, van Wijnen AJ, Last TJ, Bortell R, Stein JL, Lian JB, Stein GS (1993): Concerted control of multiple histone promoter factors during cell density inhibition of proliferation in osteosarcoma cells: reciprocal regulation of cell cycle-controlled and bone-related genes. Cancer Res 53:2399-2409.
48. Wahle E, Mueller K, Orr E (1984): Gene expression in a temperature-sensitive gyrB mutant of Escherichia coli. EMBO J 3:315-320.
49. Wang JC, Lynch AS (1993): Transcription and DNA supercoiling. Curr Op Gene Dev 3:764-768.
50. Wang Z, Dröge P (1996): Differential control of transcription-induced and overall DNA supercoiling by eukaryotic topoisomerases in vitro. EMBO J 15:581-589.
51. Watanabe M, Tsutsui K, Tsutsui K, Inoue Y (1994): Differential expression of the topoisomerase IIα and IIβ mRNAs in developing rat brain. Neuroscience Res 19:51-57.
52. Wells NJ, Fry AM, Guano F, Norbury C, Hickson ID (1995): Cell cycle phase-specific phosphorylation of human topoisomerase II alpha. Evidence of a role for protein kinase C. J Biol Chem 270:28357-28368.
53. Woessner RD, Chung TDY, Hofmann GA, Mattern MR, Mirabelli CK, Drake FH, Johnson RK (1990): Differences between normal and ras-transformed NIH-3T3 cells in expression of the 170 kD and 180 kD forms of topoisomerase II. Cancer Res 50:2901-2908.
54. Woessner RD, Mattern MR, Mirabelli CK, Johnson RK, Drake FH (1991): Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells. Cell Growth Diff 2:209-214.
55. Yamauchi M, Ogata Y, Kim RH, Li JJ, Freedman LP, Sodek J (1996): AP-1 regulation of the rat bone sialoprotein gene transcription is mediated through a TPA response element within glucocorticoid response unit in the gene promoter. Matrix Biology 15:119-130.
56. Zandvliet DWJ, Hanby AM, Austin CA, Marsh KL, Clark IBN, Wright NA, Poulsom R (1996): Analysis of foetal expression sites of human type II DNA topoisomerase α and β mRNAs by in situ hybridisation. Biochim Biophys Acta 1307:239-247.
57. Zini N, Santi S, Ognibene A, Bavelloni A, Neri LM, Valmore A, Mariani E, Negri C, Astaldi-Ricotti GCB, Maraldi NM (1994): Discrete localization of different DNA topoisomerases in HeLa and K562 cell nuclei and subnuclear fractions. Exp Cell Res 210:336-348.